Thromboelastographic Changes in Patients Experiencing an Acute Ischemic Stroke and Receiving Alteplase
Conclusions: Our study suggests that thromboelastogram (TEG) is a useful tool for determining changes in the coagulation system of patients whom have received recombinant tissue plasminogen activator (rt-PA). Further study is needed to determine if TEG can be used to predict those patients who may be at higher risk of adverse events because of rt-PA.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: A. Shaun Rowe, Christal L. Greene, Carolyn C. Snider, Roger C. Carroll, Brian F. Wiseman, Jennifer M. Henry, J. Russell Langdon, Robert M. Craft Tags: Original Articles Source Type: research
More News: Activase | Emergency Medicine | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Stroke | Study